RJA
TECH icon

Ross\Johnson & Associates’s Bio-Techne TECH Stock Holding History

Ross\Johnson & Associates’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29K Hold
63
– – 0.06% 57
2025
Q4 		$3.71K Sell
63
-1
-2% -$61 0.07% 56
2025
Q3 		$3.56K Hold
64
– – 0.07% 57
2025
Q2 		$3.29K Hold
64
– – 0.07% 51
2025
Q1 		$3.75K Hold
64
– – 0.06% 106
2024
Q4 		$4.61K Buy
+64
New +$4.7K 0.11% 48

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ross\Johnson & Associates's TECH Position: Q1 2026 in Review

Ross\Johnson & Associates held its Bio-Techne (TECH) position steady in Q1 2026 at 63 shares worth $3.29K. The position accounts for 0.06% of the portfolio, ranked #57.

Ross\Johnson & Associates first reported a position in TECH in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.61K in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Ross\Johnson & Associates held 63 shares of Bio-Techne worth $3.29K as of Q1 2026.
  • Ross\Johnson & Associates left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up 0.06% of Ross\Johnson & Associates's portfolio in Q1 2026, its #57 holding.
  • Ross\Johnson & Associates first reported a position in Bio-Techne in Q4 2024 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Bio-Techne position peaked at $4.61K in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.